×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INO – inovio pharmaceuticals, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/26
02:09 pm
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/18
08:05 am
ino
INOVIO to Participate in December Investor Conferences
Medium
Report
INOVIO to Participate in December Investor Conferences
11/14
07:08 pm
ino
Individual investors invested in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) lost 13% last week, institutions remained on the sidelines [Yahoo! Finance]
Medium
Report
Individual investors invested in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) lost 13% last week, institutions remained on the sidelines [Yahoo! Finance]
11/14
09:05 am
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
Medium
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
11/14
09:05 am
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Medium
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
11/12
09:56 am
ino
Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress [Seeking Alpha]
Medium
Report
Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress [Seeking Alpha]
11/11
08:40 am
ino
INOVIO Announces Pricing of $25 Million Public Offering
Low
Report
INOVIO Announces Pricing of $25 Million Public Offering
11/11
12:30 am
ino
Inovio Pharmaceuticals Inc (INO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Low
Report
Inovio Pharmaceuticals Inc (INO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
MISS
Report
-7.0%
inovio pharmaceuticals, inc.
8/12/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
14.1%
inovio pharmaceuticals, inc.
5/13/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
-2.1%
inovio pharmaceuticals, inc.
3/18/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
-8.4%
inovio pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
11/14
08:01 pm
ino
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Alyeska Investment Group, L.P.
Medium
Report
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Alyeska Investment Group, L.P.
11/14
10:34 am
ino
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: JANUS HENDERSON GROUP PLC
Medium
Report
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: JANUS HENDERSON GROUP PLC
11/14
08:16 am
ino
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Deep Track Capital, LP
Medium
Report
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Deep Track Capital, LP
11/13
09:16 am
ino
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P.
Low
Report
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P.
11/12
06:16 am
ino
Form 8-K INOVIO PHARMACEUTICALS, For: Nov 11
Low
Report
Form 8-K INOVIO PHARMACEUTICALS, For: Nov 11
11/12
06:13 am
ino
Form 424B5 INOVIO PHARMACEUTICALS,
Low
Report
Form 424B5 INOVIO PHARMACEUTICALS,
11/12
06:03 am
ino
Form 424B5 INOVIO PHARMACEUTICALS,
Low
Report
Form 424B5 INOVIO PHARMACEUTICALS,
11/10
04:08 pm
ino
Form 8-K INOVIO PHARMACEUTICALS, For: Nov 10
Medium
Report
Form 8-K INOVIO PHARMACEUTICALS, For: Nov 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/3
Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800
66.7%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
TOP News Decliners
3/9
Form 8-K INOVIO PHARMACEUTICALS, For: Mar 03
-47.6%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: